Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2988451000168114 | Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 3047361000168112 | Anzemet (dolasetron mesilate monohydrate 12.5 mg / 0.625 mL) injection, 0.625 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3087991000168110 | Anzemet (dolasetron mesylate monohydrate 12.5 mg / 0.625 mL) injection, 0.625 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | Is a | Anzemet | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | Is a | dolasetron mesilate monohydrate 12.5 mg/0.625 mL injection, ampoule | true | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 983375836 | |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | has intended active ingredient | dolasetron | true | Inferred relationship | Some | 983375835 | |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | has Australian BoSS | dolasetron mesilate monohydrate | true | Inferred relationship | Some | 983375835 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | has TPUU | True | Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | Inferred relationship | Some | 1 |
| Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | has TPUU | True | Anzemet 12.5 mg/0.625 mL injection, 0.625 mL ampoule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR